Publications by authors named "James D Lord"

Claim this Profile
V
Vedolizumab Efficacy Is Associated With Decreased Intracolonic Dendritic Cells, Not Memory T Cells.
Elisa K Boden, Ramya Kongala, Duncan C Hindmarch, Donna M Shows, Julius G Juarez, James D Lord

Inflamm Bowel Dis· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomic Differences in Colonic Epithelial Cells in Ulcerative Colitis Have an Epigenetic Basis.
Scott Jelinsky, Isac Lee, Mara Monetti, Susanne Breitkopf, Flora Martz, James D Lord

Gastro Hep Adv· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
Janus Kinase Inhibitors Differentially Inhibit Specific Cytokine Signals in the Mesenteric Lymph Node Cells of Inflammatory Bowel Disease Patients.
Duncan C Hindmarch, Sofya Malashanka, Donna M Shows, Astrid S Clarke, James D Lord

J Crohns Colitis· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulatory T cells use heparanase to access IL-2 bound to extracellular matrix in inflamed tissue.
Hunter A Martinez, Ievgen Koliesnik, Gernot Kaber, Jacqueline K Reid, Nadine Nagy, James D Lord

Nat Commun· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T Cell Repertoire Homogeneity and Blood-Gut Overlap in Patients With Inflammatory Bowel Disease.
Kyle G Williams, Ramya Kongala, Donna M Shows, Andrew J Konecny, Duncan C Hindmarch, James D Lord

Cell Mol Gastroenterol Hepatol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Colonic mucosal associated invariant T cells in Crohn's disease have a diverse and non-public T cell receptor beta chain repertoire.
Andrew J Konecny, Donna M Shows, James D Lord

PLoS One· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FOXP3 regulatory T cells use heparanase to access IL-2 bound to ECM in inflamed tissues.
Hunter A Martinez, Ievgen Koliesnik, Gernot Kaber, Jacqueline K Reid, Nadine Nagy, James D Lord

bioRxiv· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MAdCAM-1 Costimulates T Cells through Integrin αβ to Cause Gene Expression Events Resembling Costimulation through CD28.
Hannah A DeBerg, Andrew J Konecny, Donna M Shows, James D Lord

Immunohorizons· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Escherichiacoli-Specific CD4+ T Cells Have Public T-Cell Receptors and Low Interleukin 10 Production in Crohn's Disease.
Amiko M Uchida, Elisa K Boden, Eddie A James, Donna M Shows, Andrew J Konecny, James D Lord

Cell Mol Gastroenterol Hepatol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PGD2 and CRTH2 counteract Type 2 cytokine-elicited intestinal epithelial responses during helminth infection.
Oyebola O Oyesola, Michael T Shanahan, Matt Kanke, Bridget M Mooney, Lauren M Webb, James D Lord

J Exp Med· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of Candidate Biomarkers Associated with Response to Vedolizumab in Inflammatory Bowel Disease.
Elisa K Boden, Donna M Shows, Michael V Chiorean, James D Lord

Dig Dis Sci· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating integrin alpha4/beta7+ lymphocytes targeted by vedolizumab have a pro-inflammatory phenotype.
James D Lord, S Alice Long, Donna M Shows, Jerill Thorpe, Katherine Schwedhelm

Clin Immunol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD4 T Cells in IBD: Crossing the Line?
Elisa K Boden, James D Lord

Dig Dis Sci· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thiopurine use associated with reduced B and natural killer cells in inflammatory bowel disease.
James D Lord, Donna M Shows

World J Gastroenterol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human Blood and Mucosal Regulatory T Cells Express Activation Markers and Inhibitory Receptors in Inflammatory Bowel Disease.
James D Lord, Donna M Shows, Janice Chen, Richard C Thirlby

PLoS One· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Promises and paradoxes of regulatory T cells in inflammatory bowel disease.
James D Lord

World J Gastroenterol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case of fatal idiopathic enteritis and multiple opportunistic infections associated with dendritic cell deficiencies.
James D Lord, Janice Chen, Richard A Kozarek

J Gastrointestin Liver Dis· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paradoxically increased FOXP3+ T cells in IBD do not preferentially express the isoform of FOXP3 lacking exon 2.
James D Lord, Karine Valliant-Saunders, Hejin Hahn, Richard C Thirlby, Steven F Ziegler

Dig Dis Sci· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Confocal endomicroscopic evaluation of colorectal squamous metaplasia and dysplasia in ulcerative colitis.
James D Lord, Melissa P Upton, Joo Ha Hwang

Gastrointest Endosc· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ECM components guide IL-10 producing regulatory T-cell (TR1) induction from effector memory T-cell precursors.
Paul L Bollyky, Rebecca P Wu, Ben A Falk, James D Lord, S Alice Long

Proc Natl Acad Sci U S A· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood and gastric FOXP3+ T cells are not decreased in human gastric graft-versus-host disease.
James D Lord, Robert C Hackman, Ted A Gooley, Brent L Wood, Amanda C Moklebust

Biol Blood Marrow Transplant· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Refractory colitis following anti-CTLA4 antibody therapy: analysis of mucosal FOXP3+ T cells.
James D Lord, Robert C Hackman, Amanda Moklebust, John A Thompson, Celestia S Higano

Dig Dis Sci· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retraction. Uncoupling IL-2 signals that regulate T cell proliferation, survival, and Fas-mediated activation-induced cell death.
Luk Van Parijs, Yosef Refaeli, James D Lord, Brad H Nelson, Abul K Abbas

Immunity· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation.
Jacob Alexander, James D Lord, Matthew M Yeh, Carlos Cuevas, Ramasamy Bakthavatsalam

Liver Transpl· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cutting edge: high molecular weight hyaluronan promotes the suppressive effects of CD4+CD25+ regulatory T cells.
Paul L Bollyky, James D Lord, Susan A Masewicz, Stephen P Evanko, Jane H Buckner

J Immunol· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis